Comparision of early and late human milk fortification on growth ,osteopenia and feeding tolerance in preterm newborns in shariati hospital from 2012- 2013.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201301239568N4

Enrollment

Registered

2013-12-20

Start date

2012-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

weight gain. failure to weight gain

Interventions

Intervention 1: Intervention group: using fortifier, which is 3.6 gram sachet for25 ccmother milk . Intervention 2: Control group:preterm infant late human milk fortification from 5o-100 cc/kg feedin

Prevention

Intervention group: using fortifier, which is 3.6 gram sachet for25 ccmother milk .

Control group:preterm infant late human milk fortification from 5o-100 cc/kg feeding

Eligibility

Sex/Gender

All

Age

28 Years to 34 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All pretem infants 28-34 weeks Exclusion criteria: infants less 28 weeks and more 34 week; major congenital anomay; lemergency surjery (PDA ROP,...); infant hospitalize less 7 days; infant transfer to other care system

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Weight gain of infants. Timepoint: at birth, pre intervention and 4 weeks ago. Method of measurement: with digital scale.;Osteopenia. Timepoint: 6weeks ago. Method of measurement: serum calsum,serum phosphor,serum Alkalin phosphatase and serum vitamin -D measure.;Po intolelance. Timepoint: Daily during the intervention. Method of measurement: Around the abdomen, bowel sounds, gastric lavage, fecal occult blood and full of feces.	—

Measure

Time frame

Weight gain of infants. Timepoint: at birth, pre intervention and 4 weeks ago. Method of measurement: with digital scale.;Osteopenia. Timepoint: 6weeks ago. Method of measurement: serum calsum,serum phosphor,serum Alkalin phosphatase and serum vitamin -D measure.;Po intolelance. Timepoint: Daily during the intervention. Method of measurement: Around the abdomen, bowel sounds, gastric lavage, fecal occult blood and full of feces.

—

Secondary

Measure	Time frame
Sepsis. Timepoint: Daily during the intervention. Method of measurement: phisical exam and labratory.;NEC. Timepoint: Daily during the intervention. Method of measurement: physical exam,labratory ,radiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Marzieh Asgharyan

Tehran University of Medical Sciences

asgharyan_m@yahoo.com+98 21 7757 3797

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026